NEW YORK (GenomeWeb) – Nanosphere reported after the close of the market Wednesday that its fourth quarter net loss increased to $9.5 million, or $.08 per share, from $8.8 million, or $.11 per share, for the fourth quarter of 2013, as the firm continues to evaluate strategic alternatives.

Its loss per share beat the consensus Wall Street estimate of $.10.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.